Gov Phil Murphy Signs Executive Order Calling For Expansion of the NJ Medical Marijuana Program
Gov. Phil Murphy recently addressed a campaign promise to make New Jersey more cannabis-friendly by signing an executive order requiring a review and expansion of the State’s medical marijuana program.
In 2010, New Jersey legalized medical use of marijuana with the enactment of the New Jersey Compassionate Use Medical Marijuana Act. The New Jersey Department of Health implemented the Act by creating the New Jersey Medical Marijuana Program (MMP). The MMP authorizes approved physicians to disburse up to two ounces of medical marijuana to a registered patient during any 30-day period to treat numerous “debilitating medical conditions,” particularly where conventional treatments are ineffective or exacerbate a patient’s suffering.
Although New Jersey launched its medical marijuana program several years ago, there are still only five alternative treatment centers (ATCs) in the state, with one more dispensary on the way. In addition, only 15,000 patients are currently enrolled in the program. The low numbers reflect the number of regulatory hoops that doctors, patients, and dispensaries must jump through to participate. By way of comparison, the medical marijuana program in Michigan, a state with a similar population to New Jersey, currently serves over 218,000 patients. In addition, the program in Arizona, a state with a smaller population than New Jersey, serves over 136,000 patients.
Expanding Access to Medical Cannabis in New Jersey
Under Gov. Murphy’s executive order, the Department of Health (Department) and the Board of Medical Examiners (Board) must review all aspects of New Jersey’s medical cannabis program, including but not limited to:
An evaluation of the current rules regulating the operations and siting of dispensaries and cultivation facilities, particularly focusing on whether the rules should be revised to remove unwarranted obstructions to expansion;
A review of the current process for obtaining a license to operate a medical marijuana dispensary, including recommendations to expedite that process;
An examination of conditions for participating physicians in the program to ensure that any such requirements are not needlessly onerous;
An analysis of the current list of debilitating medical conditions for which medical marijuana may be authorized, and a recommendation as to whether doctors should be given the flexibility to make these determinations on their own;
An assessment of the methods by which patients or their primary caregivers are obtaining medical marijuana and a recommendation of whether rules should be amended to approve additional methods that could facilitate patient access;
A review of regulations that govern the forms in which medical marijuana can be ingested, taking into consideration the needs for different methods for different patients; and
Any other aspect of the program within the Department or the Board’s discretion that hinders or fails to effectively achieve the statutory objective of ensuring safe access to medical marijuana for patients in need.
The Department’s study must be completed in 60 days, after which the rulemaking process necessary to reform the program will begin. This timeline, combined with the recent opposition to Gov. Murphy’s plans for full legalization of an adult-use cannabis market in New Jersey, may result in the relatively quick development and expansion of the State’s medical program during the Murphy administration.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
Corporate Consolidation and Antitrust Issues in Mergers
Corporate consolidation involves two or more businesses merging to become a single larger entity. The result is often a stronger and more competitive company that can better navigate today’s competitive marketplace. What Is Corporate Consolidation? Corporate consolidation closely resembles a basic merger transaction. The primary difference is that a consolidation creates an entirely new business […]
Business law plays a critical role in nearly every aspect of running a successful enterprise, from negotiating a commercial lease to drafting employee policies to fulfilling corporate disclosure obligations. Understanding what is business law and your legal obligations can help your business run smoothly and build productive relationships with clients, business partners, regulators, and others. […]
Corporate Transactions: Best Practices for Successful Deals
Corporate transactions can have significant implications for a corporation and its stakeholders. For deals to be successful, companies must act strategically to maximize value and minimize risk. It is also important to fully understand the legal and financial ramifications of corporate transactions, both in the near and long term. Understanding Corporate Transactions The term “corporate […]
How to Conduct a Fair and Legal Employee Termination in 2025
Ongoing economic uncertainty is forcing many companies to make tough decisions, which includes lowering staff levels. The legal landscape on both the state and federal level also continues to evolve, especially with significant changes to the priorities of the Equal Employment Opportunity Commission (“EEOC”) under the Trump Administration. Terminating an employee is one of the […]
Admin Dissolution for Annual Report: What You Need to Know
While filing annual reports may seem like a nuisance, failing to do so can have significant ramifications. These include fines, reputational harm, and interruption of your business operations. In basic terms, “admin dissolution for annual report” means that a company is dissolved by the government. This happens because it failed to submit its annual report […]
Antitrust laws are designed to ensure that businesses compete fairly. There are three federal antitrust laws that businesses must navigate. These include the Sherman Act, the Federal Trade Commission Act, and the Clayton Act. States also have their own antitrust regimes. These may vary from federal regulations. Understanding antitrust litigation helps businesses navigate these complex […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
